Screener
AngioDynamics ANGO Operating Income
Operating Income at other companies
Other financials
Where this comes from
Reported directly by AngioDynamics in its filing.
Tagged under the XBRL concept us-gaap:OperatingIncomeLoss.
The source filing: AngioDynamics’s 10-K, filed July 14, 2026.
- Filed
- Jul 14, 2026, 3:42 PM EDT
- Fiscal year
- FY2026
- Accession
- 0001628280-26-048138
| Line item | Year ended May 31, 2026 | Year ended May 31, 2025 | Year ended May 31, 2024 |
|---|---|---|---|
| Acquisition, restructuring and other items, net | 17,598 | 15,620 | 53,182 |
| Total operating expenses | 214,819 | 197,659 | 401,632 |
| Gain on sale of assets | — | — | 54,499 |
| Operating loss | (39,927) | (39,954) | (192,435) |
| Other expenses | |||
| Interest income (expense), net | (299) | 978 | 1,614 |
| Other income (expense), net | 3,926 | 4,944 | (817) |
| Total other income, net | 3,627 | 5,922 | 797 |
Item 15. Exhibits, Financial Statement Schedules.
FAQ
- What is AngioDynamics's operating income?
- AngioDynamics (ANGO) reported operating income of -$10.2M in Q1 2026.
- How has AngioDynamics's operating income changed year-over-year?
- AngioDynamics's operating income decreased by 76.1% year-over-year, from -$5.79M to -$10.2M.
- What is the long-term trend for AngioDynamics's operating income?
- Over 4 years (2022 to 2026), AngioDynamics's operating income has grown at a 8.8% compound annual growth rate (CAGR), from -$28.47M to -$39.93M.
- What does operating income mean?
- Gross profit minus all operating expenses (SG&A, R&D, D&A). Measures the profit from core business operations before interest, taxes, and non-operating items.
Ask your AI about AngioDynamics's operating income.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude